Monday - November 16, 2026
Drug From Stony Brook-Developed Anti-Cancer Compounds Now in Clinical Trials
November 05, 2026
STONY BROOK, New York, Nov. 5 -- The State University of New York Stony Brook University posted the following news:

* * *

Drug From Stony Brook-Developed Anti-Cancer Compounds Now in Clinical Trials

*

The investigational new drug resulted from research on next-generation taxanes in Dr. Iwao Ojima's medicinal chemistry laboratory

STONY BROOK, NY, November 5, 2026 - A promising new cancer chemotherapeutic agent from a taxane cla . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products